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Introduction
Interictal spikes are not used as outcome parameter in the evaluation of therapies because the relationship between interictal spikes and seizures is uncertain. Sufficient data are available on acute changes in spike-rates before and following seizures as well as after acute drug administration. However, there is hardly any knowledge about possible therapeutically induced sub-acute or chronic electroencephalographic (EEG) changes related to seizure reduction. The interictal spike-rate may reflect a state of neuronal excitability, to be altered by anti-epileptic regimens. Chronic EEG changes paralleling or preceding clinical effects could be useful parameters in the development of therapies, being more objective than subjective *Corresponding author. Tel.: +31-40-2279022. E-mail address: scmebus@wishmail.net (S.C.M. Ebus).
seizure estimations. In a few previous studies spike counts have been applied. Lamotrigine significantly reduced overall interictal spike-rates comparing 24-h-EEGs pre/post 4 months of treatment (21 refractory patients) 1 and in nocturnal EEGs with 3 months of treatment (13 refractory patients). 2 Similar results were shown for Topiramate (23 patients, not refractory) comparing 24-h EEGs after 4-6 months. 3 In these studies, the authors did not correlate spike counts with seizure counts.
In this pilot, we assessed interictal spike-rates correlated to subjective seizure counts after intervention with vagus nerve stimulation (VNS). Spikes/minute as well as spikebursts/minute were calculated. Spikes occurring at very short intervals (spikebursts) may reflect a higher state of excitability of the epileptic cortex than isolated spikes. The clinical and neuropsychological effects of VNS after 6 months in 16 of the 19 patients were published earlier. 4 
Method Patients
Nineteen children with refractory epilepsy in which VNS (by NeuroCybernetic Prosthesis developed by Cyberonics, Webster, TX) was to be introduced were included. Mean age at implantation was 11 years (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . Clinical syndromes are shown in Table 1 .
Data collection
Seizures were reported from 6 months prior to 24 months post VNS. Five or more clustered seizures were counted as one seizure. Medication changes were not allowed in the first 6 months of VNS. Exceptions: patient 1, discontinuation of Valproate (450 mg) (loss of appetite) and patient 5, discontinuation of Lamotrigine (50 mg) (behavioral problems).
Five wake 30-min 32-channel EEGs were performed: one before and four each half year after VNS. The stimulator was not switched off. Spikes were detected by Persyst Spike Detector ® and LGSV 8/M Unknown 14 17 SME 6/F Unknown 10 18
LGS 13/M Unknown 59 19 SME 9/M Unknown 10
LGS: Lennox Gastaut Syndrome.
LGSV: Lennox Gastaut Syndrome-variant. 
Results
Not every patient could be included in each analysis because of a missing EEG (patients 1, 5, 17, 18) or a failing stimulator (patient 3, at 7th month).
Changes in seizure frequency
All 19 patients were on protocol. Mean monthly seizure frequency changed significantly comparing the 6 months with VNS to the baseline period (P = 0.03 Wilcoxon). Three patients showed more than 50% seizure reduction: patients 2, 11 and 15. They were at the lower spectrum of baseline monthly seizure frequencies (Fig. 1a) . Patient 15 became seizure free. With exclusion of this patient the overall change in seizure frequency was still significant. 
EEG at 6 months of VNS
On protocol were 16 patients (all minus 1, 17, 18). No overall changes in spikes/minute or spikebursts/minute were found at 6 months compared to the baseline EEG. Overall spike-rate in the EEG at 6 months was 20.1 (±35.1, range 0-132.1) compared to a baseline value of 21.7 (±25.6, range 0.2-78.2) spikes/minute. Overall spikeburst-rate at 6 months was 0.9 (±1.9, range 0-5.7) compared to a baseline of 1.1 (±2.0, range 0-6.0) spikebursts/minute. Responders had stable spike-and spikeburst-rates in baseline-and 6 months-EEG. Their spike-and spikebursts-rates were at the lower spectrum when compared to the non-responders (Fig. 1b and c) .
Correlation analysis
Sixteen patients (all but 1, 3, 5) were on protocol for the correlation of mean 2-year seizure frequency and mean spike/spikeburst-rate of four EEGs post VNS. The use of mean data was allowed because there were no significant changes in serial data post VNS (Friedman's test). Significant correlations between reported seizures and spikes (Spearman's R = 0.61) and between seizures and spikebursts (R = 0.74) were found ( Fig. 2a and b ).
Discussion and conclusions
We assessed the use of interictal epileptic EEG activity as outcome parameter in 19 patients with severe childhood epilepsies. In the three responders, spike-and spikeburst-rates at 6 months did not differ from baseline. Within the period of 2 years post VNS in which overall seizure-frequency and interictal epileptic activity both were stable, a significant correlation was found between spike-rate and reported seizure frequency (R = 0.61). Bursts of spikes predicted seizure frequency even better than spike-rates (R = 0.74). This seems to confirm our hypothesis that interictal epileptic activity reflects a state of neuronal excitability related to seizure frequency. The correlation of spikes with seizures could however also result from post-ictal elevation of spikes, a phenomenon shown before in refractory patients. 5 An additional observation that may well fit into the hypothesis of spikes reflecting excitability was the smaller baseline interictal spike-rate together with a lower baseline seizure frequency in the three responders. Spike-rates may predict the chance of responsiveness to interventions. In only one previous study chronic EEG-effects of VNS were examined in four EEGs within 1 year. 6 Five patients with frequent repetitive spikes showed a gradual increase of spike-free interval duration. The other 16 showed a significant gradual decrease of spikes in the serial EEGs. The author states that ''no direct correlation of the extent of seizure reduction with the degree of spike reduction'' was found. One must realize that effect sizes of seizure reduction may be overestimated in open studies. Hence the true effect sizes in Koo's as well as in our pilot study may be smaller which may cause the inability to show a spike reduction related to seizure reduction, overall or in individuals (responders).
In conclusion, the finding of a correlation between spikes and reported seizures is an encouragement to go on with trials with quantitative EEG analysis following interventions. In future studies, however, the detection of post-intervention spike-reduction may only be possible in larger patient groups and with a larger effect size, preferably in a (placebo-) controlled design.
